CD19 and hepatocellular carcinoma: Although there was no significant difference between the two groups of participants in the frequency of CD19+ B lymphocytes (Figure 4A), the frequency of B10 cells in HCC patients was significantly higher than that in healthy donors (Figure 4B), which indicated that B10 cells may play a key role in HCC progress.